Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
|
|
Integrated Regional Information Networks - December 22, 2004
JOHANNESBURG (PLUSNEWS) - Two drug-manufacturing firms this week launched a collaboration to develop the first single-dose daily combination antiretroviral drug to treat HIV-positive people.
The combination pill, to be manufactured by Gilead and Bristol-Myers Squibb, could be approved and marketed by late 2006, the Kaisernetwork news service reported.
The combined medication will include Bristol-Myers Squibb's Sustiva and Gilead's Viread and Emtriva. The current wholesale price of the three drugs sold separately is about US $35 a day. According to the Kaisernetwork, a single-dose pill would make it "much easier" for HIV/AIDS patients to adhere to their treatment regimen.
Currently, antiretroviral treatment requires patients to take several pills a day, sometimes at specific times and under certain conditions, which can make it difficult for them to comply with the requirements.
041222
IR041276
Copyright © 2004 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .